tradingkey.logo

U.S. RESEARCH ROUNDUP-Albemarle, Moderna, Newmont

ReutersFeb 16, 2026 7:43 AM

- Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Albemarle, Moderna and Newmont, on Monday.

HIGHLIGHTS

Albemarle ALB.N: RBC raises target price to $216 from $200

Moderna MRNA.O: RBC raises target price to $30 from $25

Newmont NEM.N: Jefferies raises target price to $158 from $136

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

Albemarle ALB.N: RBC raises target price to $216 from $200

Cognex Corp CGNX.O: Daiwa Capital Markets raises target price to $65 from $45

Dupont DD.N: RBC raises target price to $60 from $51

Eagle Materials Inc EXP.N: JP Morgan cuts target price to $215 from $230

Eagle Materials Inc EXP.N: JP Morgan cuts to underweight from neutral

Expedia Group Inc EXPE.O: Jefferies cuts target price to $240 from $285

Maplebear Inc CART.O: Jefferies cuts target price to $38 from $44

Moderna MRNA.O: Jefferies raises target price to $37 from $30

Moderna MRNA.O: RBC raises target price to $30 from $25

Newmont NEM.N: Jefferies raises target price to $158 from $136

Royal Gold Inc RGLD.O: Jefferies raises target price to $390 from $320

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI